21-22 April 2026
Coventry Building Society Arena
Hall(s): Making Nutraceuticals
Stand: 902
Category: Botanical & Herbal Extract Development, Clinical & Consumer Studies for Nutraceuticals, Consumer Health, Dietary Supplement Manufacturing, Making Nutraceuticals
Telephone: +44 (0)1993 880 700
Email: info@phynova.com
Website: https://www.phynova.com/
Phynova Group Ltd. is a British life science company specialising in the development and commercialisation of unique, scientifically supported botanical ingredients.
Our flagship ingredient Reducose® is a patented mulberry leaf extract supported by more than 13 clinical studies, demonstrating reductions in post-meal glucose and insulin spikes of up to 42%. Taken alongside carbohydrate-containing meals, Reducose® delivers an immediate effect that consumers can observe in real time using continuous glucose monitors (CGMs). These stabilised post-meal glucose responses are associated with steadier energy levels, improved focus and sleep, and increased satiety consumers can feel.
Effective at a low serving size of just 250 mg, Reducose® has been commercialised in over 375 million servings worldwide. Water-soluble, heat-stable, long shelf life, pH and light stable with a low taste impact, Reducose® free flowing powder offers a broad range of formulation possibilities for dietary supplements.
« Back
